Clomipramine/sildenafil - CTC Bio

Drug Profile

Clomipramine/sildenafil - CTC Bio

Alternative Names: CDFR-0812

Latest Information Update: 28 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CTCBIO
  • Class Erectile dysfunction therapies; Small molecules
  • Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors; Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Premature ejaculation

Most Recent Events

  • 01 Nov 2015 Phase-II clinical trials in Premature ejaculation in South Korea (PO)
  • 26 Oct 2015 CTC Bio plans a phase II trial for Premature ejaculation in South Korea (NCT02571101)
  • 01 Oct 2015 Preclinical trials in Premature ejaculation in South Korea (PO) before October 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top